Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Endocrinology | Family Medicine
Disease Category: Diabetes Mellitus, Type 2
Location: United States, NY

Clinical Trial Details

Overview

Research Study Summary

Type 2 Diabetes - patients after an Acute Coronary Syndrome

Purpose

Winthrop University Hospital Clinical Trials Center is seeking volunteers 30 years and older who have been diagnosed with type 2 diabetes and recently hospitalized with a coronary event. The purpose of this research study is to evaluate the effectiveness of an investigational drug in preventing cardiovascular events by lowering the blood sugar in patients with Type II diabetes.

Eligible participants will receive study-related medical examinations, research medication and laboratory tests at no cost, while they are participating in this research study. Compensation may be provided for time and travel.

To be eligible for the study, you must;

  • be over 30 years old
  • be diagnosed with type 2 diabetes
  • be diagnosed with cardiovascular disease such as heart attacks and stroke

To Learn more
Phase

3

Gender

Both Male and Female

Age

30 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Study Nurse, Study Nurse
Winthrop University Hospital Clinical Trials Center
222 Station Plaza North Suite 300
Mineola, NY 11501
Phone: 516-663-9582

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 176850

Date Last Changed: July 22, 2013


DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.